Article
Detection of tumor-derived cell-free DNA in cerebrospinal fluid using a clinically validated targeted sequencing panel for pediatric brain tumors.
Journal of neuro-oncology - 1 Jun 2024
Ronsley Rebecca, Karvonen Kristine A, Cole Bonnie, Paulson Vera, Stevens Jeff, Crotty Erin E, Hauptman Jason, Lee Amy, Stasi Shannon M, Lockwood Christina M, Leary Sarah E S
Abstract excerpt
PURPOSE: Clinical sequencing of tumor DNA is necessary to render an integrated diagnosis and select therapy for children with primary central nervous system (CNS) tumors, but neurosurgical biopsy is not without risk. In this study, we describe cell-free DNA (cfDNA) in blood and cerebrospinal fluid (CSF) as sources for "liquid biopsy" in pediatric brain tumors. METHODS: CSF samples were collected by lumbar...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
